Effect of chemical linkage upon the stability and cytotoxic activity of A chain immunotoxins.

[1]  D. Blakey,et al.  New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. , 1987, Cancer research.

[2]  D. Blakey,et al.  Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. , 1987, Journal of the National Cancer Institute.

[3]  D. Blakey,et al.  Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody. , 1987, Cancer research.

[4]  C. Vogel.  Immunoconjugates : antibody conjugates in radioimaging and therapy of cancer , 1987 .

[5]  W. A. Stevens,et al.  Bryodin, a ribosome-inactivating protein from the roots of Bryonia dioica L. (white bryony). , 1986, The Biochemical journal.

[6]  W. Ross,et al.  Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats. , 1986, Anti-cancer drug design.

[7]  J. Ritz,et al.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. , 1986, The Journal of clinical investigation.

[8]  W. Ross,et al.  Fate of an antibody-ricin A chain conjugate administered to normal rats. , 1986, Biochemical pharmacology.

[9]  P. Casellas,et al.  Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin. , 1986, European journal of biochemistry.

[10]  L. Barbieri,et al.  Ribosome‐inactivating proteins up to date , 1986, FEBS letters.

[11]  D. Blakey,et al.  Effect of chemical deglycosylation on the in vivo fate of ricin A-chain. , 1986, Cancer drug delivery.

[12]  A. Yau-Young,et al.  Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins. , 1985, The Journal of biological chemistry.

[13]  P. Gros,et al.  Biochemical aspects of immunotoxin preparation. , 1985, Journal of immunological methods.

[14]  F. Stirpe,et al.  An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. , 1985, Journal of the National Cancer Institute.

[15]  S. Ramakrishnan,et al.  Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood. , 1985, Cancer research.

[16]  B. Foxwell,et al.  [16] Preparation of antibody—toxin conjugates , 1985 .

[17]  C. Vogel,et al.  In vivo studies with covalent conjugates of cobra venom factor and monoclonal antibodies to human tumors. , 1985, Haematology and blood transfusion.

[18]  K. M. Hwang,et al.  Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen. , 1984, Cancer research.

[19]  P. Casellas,et al.  Significance of the Kinetics of Immunotoxin Cytotoxicity , 1984 .

[20]  V. Raso,et al.  Monoclonal Antibodies as Cell Targeted Carriers of Covalently and Non-Covalently Attached Toxins , 1984 .

[21]  R. F. Beers,et al.  Cell fusion : gene transfer and transformation , 1984 .

[22]  S. Ramakrishnan,et al.  Comparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies. , 1984, Cancer research.

[23]  G. Poste,et al.  Receptor-Mediated Targeting of Drugs , 1984, Springer US.

[24]  Jagannathan.  Modern Trends in Human Leukemia , 1983 .

[25]  Y. Masuho,et al.  Importance of the antigen-binding valency and the nature of the cross-linking bond in ricin A-chain conjugates with antibody. , 1982, Journal of biochemistry.

[26]  Y. Masuho,et al.  Targeting of the antiviral protein from Phytolacca americana with an antibody. , 1982, Biochemical and biophysical research communications.

[27]  Dominique,et al.  Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity , 1982, Immunological reviews.

[28]  P. Thorpe,et al.  The Preparation and Cytotoxic Properties of Antibody‐Toxin Conjugates , 1982, Immunological reviews.

[29]  J. Ritz,et al.  Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. , 1982, Cancer research.

[30]  A. McMichael,et al.  Monoclonal antibodies in clinical medicine , 1982 .

[31]  Y. Masuho,et al.  Cytotoxicity of a hybrid prepared by coupling diphtheria toxin A-chain with immunoglobulin Fab' with N,N'-o-phenylenedimaleimide. , 1981, Biochemical and biophysical research communications.

[32]  D. C. Edwards,et al.  Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin. , 1981, European journal of biochemistry.

[33]  M. Anderson,et al.  Direct evidence for inter-organ transport of glutathione and that the non-filtration renal mechanism for glutathione utilization involves gamma-glutamyl transpeptidase. , 1980, Biochemical and biophysical research communications.

[34]  R. Traut,et al.  Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate). , 1978, Biochemistry.

[35]  J Carlsson,et al.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. , 1978, The Biochemical journal.

[36]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.